News

An interdisciplinary gathering at the 2025 virtual conference of the Society for Digital Mental Health heard presentations and panel discussions on digital therapeutics, along with reports of studies on the technology and outcomes by student and young researchers.

Let's look at the intersection of psychiatry and the afterlife, including the beliefs, research, and personal insights on reincarnation and purpose.

Explore the transformative power of self-compassion through poetry, mentorship, and shared humanity in overcoming doubt and anxiety.

Roger S. McIntyre, MD, FRCPC, shares the backstory and pharmacology of incretins to better understand the role of GLP-1 RAs in psychiatry.

New research reveals ketamine's safe use for treating eating disorders, offering hope for patients with comorbid treatment-resistant depression.

Researchers analyze single-cell communication in brains of people with PTSD, uncovering genetic variations that could lead to new treatments for this complex disorder.

Explore essential insights and best practices in geriatric psychiatry in our July theme! Submit your insights, tips, and case studies centered on healthy aging for older adults.

These 2 compelling memoirs delve into the complexities of schizophrenia, showcasing resilience, friendship, and the impact of mental health.

New clinical trial results reveal BPL-003's rapid and durable antidepressant effects, paving the way for innovative treatments in treatment-resistant depression.

The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals.

Doctors in India face escalating burnout and violence, risking their well-being while navigating a broken health care system. This Doctor's Day, reform is urgently needed.

New research reveals how ezogabine targets potassium channels in the brain, offering innovative treatment options for major depressive disorder symptoms.

Discover how PAs like Erin Crown, MHS, PA-C, Psych-CAQ, are transforming mental health care, bridging gaps, and expanding access to psychiatric services nationwide.

Check out the pipeline updates from June!

Alto Neuroscience's ALTO-203 trial reveals mixed results, highlighting potential biomarkers for targeted depression treatment despite missing primary efficacy goals.

Explore the intriguing connections between afterlife beliefs, personal experiences, and the psychological impact of grief in this thought-provoking analysis.

Researchers uncover a novel biomarker for major depressive disorder, linking regional homogeneity in fMRI to decreased cerebral blood flow and symptom severity.

Augmented reality can transform psychiatric treatment, enhancing exposure therapy for trauma and anxiety by simulating real-world environments and interactions.

The complex ethics of dying, death, and assisted dying lead to debates on terminology and implications for patient autonomy and suffering.

In this CME article, learn more about the complexities of neuropsychiatric symptoms in Parkinson disease, including psychosis and cognitive impairment, and effective treatment strategies.

Discover the innovative Borderline Personality Disorder Inventory (BPD-I™), a psychodynamically-informed tool for assessing BPD symptoms effectively.

What is a sleep disorder? Explore the complexities of their definitions and the impact of circadian rhythms on health and well-being.

Let's explore the intriguing intersection of psychiatry and past lives, revealing how understanding previous existences can lead to personal healing and growth.

Medical trainees face challenges from patient mistreatment. Frameworks like ERASE can foster supportive learning environments.

Explore the intricate relationship between sleep disorders and psychiatric conditions, diagnostic challenges, and effective management strategies, in this Special Report article.

Compass Pathways reports significant progress in psilocybin research, showing promise for treatment-resistant depression in a pivotal phase 3 trial.

Christine Yu Moutier, MD, the chief medical officer of the AFSP, speaks about the impact of losing LGBTQ+ tailored crisis support via 988, and strategies to better support vulnerable youth.

Let's explore the psychological impacts of international conflict. We must emphasize the need for compassion and understanding to foster peace and mental health.

NRx Pharmaceuticals advances NRX-100, a preservative-free ketamine, through a fast-tracked FDA review for treating suicidal depression and PTSD.

Technology can reshape psychiatric training and leadership, bridging generational gaps while enhancing patient care and education.